06 September 2024
06 September 2024
Exer’s AI-based software analyses hand and wrist motion using a camera to diagnose conditions and recommend treatments.
The UD-X single-molecule analyser is designed for the ultra-sensitive detection of trace protein biomarkers in body fluids.
The companies plan to develop fine-tuned GenAI cancer detection models using HOPPR’s generalised medical-grade foundation model.
The plasmonic sensor utilises a gold pattern that causes electrons to create waves known as plasmons.
The company received financial backing for trialing the surgical scaffolding product from J&J’s venture capital arm.
Tmini is a small, handheld surgical implant device that assists in knee replacement surgery.
Aptar’s platform offers reminders, real-time tracking, and educational resources to manage medication and symptoms.
The combination of including biology-guided radiotherapy and Stereotactic Body Radiation Therapy comes as an upgrade to the company’s device.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
